Health · 41 views
Centers for Medicare & Medicaid Services extends short-term bridge program for GLP-1 obesity drug coverage
The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare, called the BALANCE model, will not launch as scheduled on Jan. 1, 2027.
AI Summary
The Centers for Medicare & Medicaid Services has made a decision regarding its temporary program for covering GLP-1 obesity drugs. The program, initially set to launch on January 1, 2027, will not proceed as planned.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- When doctors and AI medical opinions diverge, humans must question the difference, according to expertsContinue reading
- Cancer diagnoses in England hit record high of more than 1,000 people a dayContinue reading
- Putty-like electrode could improve vocal rehabilitationContinue reading
- Are We Overlooking Chronic Neuropathic Pain After ICU Survival?Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow